EYPT vs UNP · rev $1.2M vs P/E 21, rev $6.86B
Eyepoint Pharmaceuticals Inc (EYPT) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
EYPT currently screens at market cap $1.10B. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the EYPT and UNP stock pages for the full models.
Not investment advice.